Advances in the prevention and treatment of breast cancer-related lymphedema Paula M. C. DonahueAdrien MacKenzieLouise Koelmeyer Review Open access 27 April 2023 Pages: 1 - 14
Clinical efficacy of PARP inhibitors in breast cancer Karan PandyaAlyssa ScherMridula A. George Review 02 May 2023 Pages: 15 - 22
The mixed subtype has a worse prognosis than other histological subtypes: a retrospective analysis of 217 patients with metaplastic breast cancer Jiayue HuRonggang LangYehui Shi Preclinical study Open access 09 May 2023 Pages: 23 - 36
Comparison of initial and sequential salvage brain-directed treatment in patients with 1–4 vs. 5–10 brain metastases from breast cancer (KROG 16–12) Jae Sik KimKyubo KimIn Ah Kim Clinical trial 03 May 2023 Pages: 37 - 45
Clinical significance of microinvasive breast cancer across the different subtypes and human epidermal growth factor receptor 2 expression levels Soo-Young LeeTae-Kyung YooSae Byul Lee Clinical trial 15 May 2023 Pages: 47 - 61
Pathogenic variants among females with breast cancer and a non-breast cancer reveal opportunities for cancer interception Brittany L. BychkovskyMin-Tzu LoHuma Q. Rana Epidemiology Open access 01 March 2023 Pages: 63 - 72
Correction to: Pathogenic variants among females with breast cancer and a non‑breast cancer reveal opportunities for cancer interception Brittany L. BychkovskyMin-Tzu LoHuma Q. Rana Correction Open access 13 May 2023 Pages: 73 - 73
The impact of race and age on response to neoadjuvant therapy and long-term outcomes in Black and White women with early-stage breast cancer Elizabeth TermanJori SheadeRita Nanda Epidemiology Open access 29 April 2023 Pages: 75 - 83
Social determinants of health and CDK4/6 inhibitor use and outcomes among patients with metastatic breast cancer Claire SatheMelissa K. AccordinoDawn L. Hershman Epidemiology 08 May 2023 Pages: 85 - 92
Metformin, placebo, and endocrine therapy discontinuation among participants in a randomized double-blind trial of metformin vs placebo in hormone receptor-positive early-stage breast cancer (CCTG MA32) Dawn L. HershmanBingshu E. ChenPamela J. Goodwin Epidemiology 09 May 2023 Pages: 93 - 102
Breast cancer survivorship and sexual dysfunction: a population-based cohort study Chun-Pin ChangTiffany F. HoMia Hashibe Epidemiology 09 May 2023 Pages: 103 - 113
Nuclear magnetic resonance-determined lipoprotein profile and risk of breast cancer: a Mendelian randomization study Jinyu XiaoYu HaoBen Zhang Epidemiology 10 May 2023 Pages: 115 - 126
Breast cancer treatment receipt and the role of financial stress, health literacy, and numeracy among diverse breast cancer survivors Ashley Odai-AfoteyRuth I. LedermanRachel A. Freedman Epidemiology 13 May 2023 Pages: 127 - 137
Premenopausal women with breast cancer in the early post-partum period show molecular profiles of invasion and are associated with poor prognosis Vidya P. NimbalkarV. P. SnijeshJyothi S. Prabhu Original Laboratory Investigation Open access 09 May 2023 Pages: 139 - 149
Targeting PELP1 oncogenic signaling in TNBC with the small molecule inhibitor SMIP34 Kristin A. AltweggUday P. PratapRatna K. Vadlamudi Original Laboratory Investigation Open access 18 May 2023 Pages: 151 - 162
